Successfully managing heart failure is one the looming issues for cardiovascular medicine, with prevalence expected to grow significantly over the coming decades. The plenary session “Engineering Success in Heart Failure” looked at where things are headed, from therapy to devices to delivery of care...
Search
Displaying 121 - 140 of 1414
Once again, the University of Ottawa Heart Institute had more than 40 clinical and research presentations on the program at the annual American Heart Association Scientific Sessions. These, along with other major developments in the world of cardiovascular medicine, made for a lively conference. New...
Several Heart Institute staffers offered their expertise in invited talks touching on a broad range of topics. Scientist Erik Suuronen, PhD, uses tissue engineering techniques to develop methods for regenerating damaged heart muscle. In his presentation, called “The Matrix: Stem Cell Delivery...
Some of the biggest news to come out of AHA this year was the results from preliminary clinical trials of two new LDL cholesterol-lowering drugs that show a substantial decrease in LDL levels well below the reductions seen with statins or ezetimibe alone. The new drugs belong to a class called PCSK9...
The use of stem cells for regenerating damaged heart tissue offers great potential, but many technical questions remain. Understanding which cell types are most beneficial and how they should be employed is a central issue. Several clinical trials involving stem cells were presented at AHA. Two were...
Research from around the world was presented at the 2014 American Heart Association (AHA) Scientific Sessions in November. The following highlights range from large drug trials to new information about the causes and of heart disease and the value of good heart health. Preventing Clots Following...
More than 32,000 Canadians go into cardiac arrest each year outside of a hospital and more than 90 per cent of them die. In many cases, this is because bystanders didn’t have adequate knowledge of CPR or access to an automated external defibrillator (AED). Guidelines and studies presented at the...
Although most cases of high blood pressure have no easily identifiable cause, the condition’s effects are clear, including increased risk of stroke, heart attack, and heart failure. The medical consensus is that using medications to lower blood pressure benefits patients, but how low has remained an...
Over the last decade, much has been learned about the genetic risk factors for cardiovascular disease. In the long run, as researchers uncover how variations in these genes lead to heart disease, this knowledge may lead to new preventive drugs and treatments. But in the meantime, doctors have been...
Canadians eat more salt than is good for them, increasing their risk of high blood pressure, heart disease, and stroke. The Heart and Stroke Foundation estimates that the average adult Canadian consumes about 3,400 mg of sodium per day (roughly one-and-a-half teaspoons), most of it from processed...
At this year’s premier international gathering for heart disease, the American Heart Association Scientific Sessions, sharing expertise was a major aspect of the University of Ottawa Heart Institute’s presence. In Ask the Expert and seminar sessions, surgeons Marc Ruel, Munir Boodhwani, David...
Dr. Zeeshan Ahmed is an interventional cardiologist at the University of Ottawa Heart Institute (UOHI) and an assistant professor in the Faculty of Medicine at the University of Ottawa.
Each of us breathes in 10,000 or more litres of air every day, so it’s no surprise that the quality of that air can impact our health. Whether in large urban centres or more rural settings, air pollution can be a fact of life. As it turns out, these airborne pollutants—ground-level ozone, nitrogen...
Talal Al-Atassi, MD, CM, MPH, FCCS, FRCSC is a surgeon in the Division of Cardiac Surgery at the University of Ottawa Heart Institute and an Associate Professor at the University of Ottawa. He currently serves as the Cardiac Surgery Residency Program Director.
Dr. Emilio I. Alarcon is a Scientist in the Division of Cardiac Surgery and Director of the Bio-nanomaterials Chemistry and Engineering Laboratory at the University of Ottawa Heart Institute. He is also an Associate Professor in the Department of Biochemistry, Microbiology and Immunology at the...
Alcohol septal ablation is a procedure used to treat obstructive hypertrophic cardiomyopathy (HCM). It is a minimally invasive procedure performed when severe symptoms cannot be controlled with drugs.
February is the shortest and coldest month of the year, but also the most important one for our heart health. That’s because February is Heart Month, a time to reflect on the importance of our cardiovascular health and to learn about how we can manage our risk factors for heart disease. The...
From physiotherapists and dietitians to medical clerks and imaging technicians, allied health trainees gain hands-on experience at the University of Ottawa Heart Institute through internships and training placements.
Dr. Wael Alqarawi is a physician in the Division of Cardiology at the University of Ottawa Heart Institute, and an assistant professor and clinical investigator in the Department of Medicine, Division of Cardiology at the University of Ottawa.
This test is not covered by OHIP. There is a fee of $100.00 payable by cash or cheque at the time of the appointment. Once your doctor has sent the referral, the Cardiac Imaging department will contact you directly to book an appointment. Please make sure your contact information is accurate. Set up...